Biohaven Pharmaceutical

Yahoo Finance • 3 months ago

Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia

Conference call and webcast to be held Monday, September 23, at 8:30am ET NEW HAVEN, Conn., Sept. 20, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven), today announced that it will host a conference call to discuss topline data... Full story

Yahoo Finance • 8 months ago

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates

Biohaven's first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at AAN highlighting its novel mechanism of action and the latest preclinical d... Full story

Yahoo Finance • 2 years ago

Hedge Funds Are Fleeing These 10 Growth Stocks. 5 Stocks They Are Buying Instead

In this article, we will look at the 10 growth stocks that hedge funds are dumping. If you want to see stocks that hedge funds are buying, you can go to 5 Stocks Hedge Funds Are Buying. Growth stocks had one of their historically worst ye... Full story

Yahoo Finance • 2 years ago

JPMorgan’s Best Performing 15 Stock Picks for 2023

In this piece, we will take a look at JPMorgan's top performing 15 stock picks for 2023. For more top stock picks, head on over to JPMorgan's Top 5 Stock Picks for 2023. As we settle into 2023, market watchers are trying to balance optimi... Full story

Yahoo Finance • 2 years ago

Mike Heffernan appointed Chairman of NMD Pharma’s Board of Directors

Mike Heffernan appointed Chairman of NMD Pharma’s Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen severalsuccessful IPOs and trade... Full story

Yahoo Finance • 2 years ago

Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University

Biohaven advances development of its extracellular target degrader platform technology (MoDEs™) for therapies across a variety of diseases including neuroscience, immunology and oncology Through its continued collaboration with Yale Univer... Full story

Yahoo Finance • 2 years ago

INVESTIGATION ALERT: Halper Sadeh LLP Investigates HMTV, BHVN, CMAX, VMW

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

Biohaven (BHVN) Begins Phase III Study on SMA Candidate

Biohaven Pharma BHVN announced the initiation of enrollment in a phase III study to assess the safety and efficacy of taldefgrobep alfa in patients with spinal muscle atrophy (SMA). SMA is an inherited progressive neuromuscular disease in... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, HMTV, SIMO, SREV

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 years ago

Lifshitz Law PLLC Announces Investigation of EMCF, FSI, BHVN, and RTLR

NEW YORK, June 18, 2022 (GLOBE NEWSWIRE) -- Emclaire Financial Corp. (NASDAQ: EMCF) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of EMCF to Farmers National Banc Corp. P... Full story

Yahoo Finance • 3 years ago

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MUDS, EMCF, FSI, BHVN

NEW YORK, June 15, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, SWCH, MICT

NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholder... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates BHVN, SWCH, TREC

NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholder... Full story

Yahoo Finance • 3 years ago

Pfizer's $11.6 bln Biohaven buy could spark more biotech deals

By Manas Mishra May 11 (Reuters) - Pfizer Inc's $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as cash-flush drugmakers look to snap up beaten-d... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PSB, SREV, HMTV, BHVN

NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholder... Full story

Yahoo Finance • 3 years ago

BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of BHVN and Encourages Investors to Contact the Firm

NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Biohaven Pharmaceutical Holding Company... Full story

Yahoo Finance • 3 years ago

10 Stocks Making Headlines Today

In this article, we will discuss some of the popular stocks trending on Tuesday. To take a look at some more stocks that are in the news, go to 5 Stocks Making Headlines Today. The S&P 500 Index and the Dow 30 Index are down 0.46% and 0.7... Full story

Yahoo Finance • 3 years ago

Nasdaq Leads Upside As Indexes Turn Positive; This Dow Jones Stock Nears Buy Point

On Tuesday, the Nasdaq broke its biggest three-day losing streak since March 2020 and led the upside among the indexes.... Full story

Yahoo Finance • 3 years ago

Stock Market Fades, Mixed At Midday; A Defensive Group Sells Off

The stock market bounced back after a three-day sell-off, rising sharply in early trading Tuesday, as a handful of big moves punctuated the session.... Full story

Yahoo Finance • 3 years ago

Stock Market Bounce Fades As S&P 500 Trims Gain To Just 0.3%

The stock market bounced back after a three-day sell-off, rising sharply in early trading Tuesday, as a handful of big moves punctuated the session.... Full story